In pivot, biotech firm that makes burn and wound treatments will start clinical trial for new drug candidate in Q2 in three US medical centers

Israeli maker of NexoBrid for the treatment of severe burns signs exclusive marketing and distribution agreement with Emirati conglomerate Ghassan Aboud Group